Based in the Wuhan Economic & Technological Development Zone in Wuhan city, in Central China's Hubei province, Wuhan Tongji Modern Pharmaceutical Technology Co is a national high-tech business that integrates drug research and development, production, sales, drug distribution and high-end medical services.
The company has a registered capital of 131 million yuan ($18.45 million), with facilities in the zone that cover an area of over 3 hectares.
The group is committed to the industrialization of medical scientific research achievements. It currently has medicinal tea, capsule, tablet, granule, spray and other medicament production lines -- offering more than 80 products -- and boasts holding more than 10 independent intellectual property rights patents.
In 2016, the company's production line successfully passed the new GMP (Good Manufacturing Practices) certification – an industry system for excellence, ensuring that products are consistently produced and controlled according to quality standards.
In the same year, the company focused on major workshop renovations and equipment upgrades, as well as completing a comprehensive technical innovation and equipment transformation. In addition, it strengthened various management requirements and strictly controlled the production process to ensure the quality and safety of its medicines.
